iShares Biotechnology ETF Rating $138.38 -0.38 (-0.27%) Closing price 04:00 PM EasternExtended Trading$138.59 +0.21 (+0.15%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.64Holdings in IBB have an aggregate rating of Moderate Buy based on 479 analyst ratings issued in the past year covering 25 companies (69.7% of the portfolio).IBB Aggregate Price Target$138.38High Prediction$138.38Average Prediction$138.38Low Prediction$138.38Holdings in IBB have an aggregate price target of $138.38 and a range of $138.38 to $138.38 covering 25 companies (69.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.74%AMGNAmgen$292.62-1.3%4.6617 of 5 stars2.33$303.76 3.8%21Positive NewsAnalyst Revision7.73%VRTXVertex Pharmaceuticals$389.88-0.7%4.9482 of 5 stars2.56$497.10 27.5%27Positive News7.68%GILDGilead Sciences$117.99-0.3%4.8752 of 5 stars2.80$114.82 -2.7%25Positive NewsAnalyst Revision6.51%REGNRegeneron Pharmaceuticals$573.91-1.1%4.8389 of 5 stars2.81$829.65 44.6%26Positive NewsDividend AnnouncementAnalyst Revision4.56%ALNYAlnylam Pharmaceuticals$456.87+1.8%4.2376 of 5 stars2.85$405.33 -11.3%26Positive NewsInsider Trade3.80%IQVIQVIA$192.58+0.8%4.9106 of 5 stars2.74$228.62 18.7%23News CoveragePositive NewsShort Interest ↓Analyst Revision2.91%MTDMettler-Toledo International$1,315.45+0.2%3.976 of 5 stars2.50$1,288.89 -2.0%10Positive NewsInsider Trade2.53%ARGXargenex$661.32+1.1%3.9525 of 5 stars3.10$746.81 12.9%20Positive News2.14%BIIBBiogen$135.91-1.9%4.8582 of 5 stars2.34$185.74 36.7%32Analyst Revision2.06%INSMInsmed$127.27-0.4%4.0924 of 5 stars2.94$129.57 1.8%16Analyst Revision2.00%NTRANatera$161.15-1.1%3.2367 of 5 stars3.06$193.19 19.9%18Analyst ForecastInsider Trade2.00%WATWaters$289.15-0.8%4.795 of 5 stars2.47$378.73 31.0%151.92%BNTXBioNTech$112.55-0.9%1.6229 of 5 stars2.76$135.80 20.7%17Analyst Revision1.87%ILMNIllumina$100.53+0.4%4.6445 of 5 stars2.25$124.58 23.9%20Positive News1.81%ONCBeOne Medicines$319.32-0.6%0.6427 of 5 stars3.00$330.89 3.6%7Insider Trade1.49%INCYIncyte$84.92-2.3%4.6934 of 5 stars2.33$81.20 -4.4%18Positive News1.49%UTHRUnited Therapeutics$314.10+0.3%4.9184 of 5 stars2.69$382.00 21.6%13Positive News1.40%NBIXNeurocrine Biosciences$133.14+0.2%4.8504 of 5 stars2.86$160.90 20.9%22Positive News1.34%EXELExelixis$37.76-1.4%4.8724 of 5 stars2.55$44.06 16.7%22Positive News1.30%MRNAModerna$28.09+0.2%4.548 of 5 stars2.04$43.59 55.2%24Options Volume1.24%BMRNBioMarin Pharmaceutical$57.44-0.2%4.9979 of 5 stars2.75$93.17 62.2%24Positive News1.16%MEDPMedpace$462.91+1.1%4.3161 of 5 stars1.93$406.60 -12.2%14Positive News1.06%GMABGenmab A/S$23.42+0.5%3.9674 of 5 stars2.64$37.60 60.5%11Positive NewsAnalyst ForecastAnalyst Revision1.01%TECHBio-Techne$53.29-0.6%4.9567 of 5 stars2.62$69.42 30.3%13Positive NewsDividend Announcement0.96%CRLCharles River Laboratories International$157.27+0.4%4.7872 of 5 stars2.27$175.69 11.7%15Analyst Downgrade This page (NASDAQ:IBB) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access